nach oben

Neurological Sciences

Erschienen in:

13.01.2021 | Original Article

A new and short protocol to achieve the early diagnosis of mild cognitive impairment

verfasst von: Sara García, Fernando Cuetos, Antonello Novelli, Carmen Martínez

Erschienen in: Neurological Sciences | Ausgabe 9/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The mild cognitive impairment (MCI) is a neurocognitive disorder which involves cognitive impairments beyond those expected for the age and education of the subject but are not significant enough to interfere with instrumental activities of daily living. The identification of individuals with MCI is particularly important for those who might benefit from new therapies. The aim of this work is to propose a comprehensive neuropsychological protocol to achieve early diagnosis of MCI.

Methods

A neuropsychological battery was created and administered to a sample of patients with MCI (n = 25) and healthy matched controls (n = 25).

Results

Although memory decline is often the first sign preceding the appearance of MCI, significant differences in visuospatial tasks, naming abilities, and executive function can be demonstrated as well between MCI and controls.

Conclusions

A proper selection of cognitive measures within those included in the already-available neuropsychological batteries may provide a thorough assessment of MCI and allow its timely diagnosis.

Murman DL (2015) The impact of age on cognition. Semin Hear 36(3):111–121. https://doi.org/10.1055/s-0035-1555115CrossRefPubMedPubMedCentral

Kral VA (1962) Senescent forgetfulness: benign and malignant. Can Med Assoc J 86(6):257–260PubMedPubMedCentral

Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139(9):1136–1139. https://doi.org/10.1176/ajp.139.9.1136CrossRefPubMed

Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256(3):183–194. https://doi.org/10.1111/j.1365-2796.2004.01388.xCrossRefPubMed

Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkinf M, Bell K, Stern Y, Devanand DP (2006) Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 63(8):916–924. https://doi.org/10.1001/archpsyc.63.8.916CrossRefPubMed

Schmidtke K, Hermeneit S (2008) High rate of conversion to Alzheimer’s disease in a cohort of amnestic MCI patients. Int Psychogeriatr 20(1):96–108. https://doi.org/10.1017/S1041610207005509CrossRefPubMed

Bozoki A, Giordani B, Heidebrink JL, Berent S, Foster NL (2001) Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol 58(3):411–416. https://doi.org/10.1001/archneur.58.3.411CrossRefPubMed

Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356. https://doi.org/10.1002/mds.24893CrossRefPubMedPubMedCentral

Goldman JG, Holden S, Ouyang B, Bernard B, Coetz CG, Sebbins GT (2014) Diagnosing PD-MCI by task force criteria: how many and which neuropsychological tests? Mov Disord 30(3):402–406. https://doi.org/10.1002/mds.26084CrossRefPubMedPubMedCentral

10.

Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Earlbaum Associates, Hillsdale

11.

Seigerschmidt E, Mösch E, Siemen M, Förstl H, Bickel H (2002) The clock drawing test and questionable dementia: reliability and validity. Int J Geriatr Psychiatry 17(11):1048–1054. https://doi.org/10.1002/gps.747CrossRefPubMed

12.

Forti P, Olivelli V, Rietti E, Maltoni B, Ravaglia G (2010) Diagnostic performance of an executive clock drawing task (CLOX) as a screening test for mild cognitive impairment in elderly persons with cognitive complaints. Dement Geriatr Cogn Disord 30(1):20–27. https://doi.org/10.1159/000315515CrossRefPubMed

13.

Ehreke L, Luck T, Luppa M, König HH, Villringer A, Riedel-Heller SG (2011) Clock drawing test – screening utility for mild cognitive impairment according to different scoring systems: results of the Leipzig Longitudinal Study of the Aged (LEILA 75+). Int Psychogeriatr 23(10):1592–1601. https://doi.org/10.1017/S104161021100144XCrossRefPubMed

14.

Cacho J, García-García R, Arcaya J, Vicente JL, Lantada N (1999) Una propuesta de aplicación y puntuación del test del reloj en la enfermedad de Alzheimer. Rev Neurol 28:648–655PubMed

15.

Hodges JR, Patterson K (1995) Is semantic memory consistently impaired early in the course of Alzheimer’s disease? Neuroanatomical and diagnostic implications. Neuropsychologia 33(4):441–459. https://doi.org/10.1016/0028-3932(94)00127-bCrossRefPubMed

16.

Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A (1992) Detection and staging of dementia in Alzheimer’s disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer’s Disease. Arch Neurol 49(5):448–452. https://doi.org/10.1001/archneur.1992.00530290030008CrossRefPubMed

17.

Welsh K, Butters N, Hughes J, Mohs R, Heyman A (1991) Detection of abnormal memory decline in mild cases of Alzheimer’s disease using CERAD neuropsychological measures. Arch Neurol 48(3):278–281. https://doi.org/10.1001/archneur.1991.00530150046016CrossRefPubMed

18.

Albert MS, Moss MB, Tanzi R, Jones K (2001) Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc 7(5):631–639. https://doi.org/10.1017/S1355617701755105CrossRefPubMed

19.

Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Brit J Psychiatry 140:566–572. https://doi.org/10.1192/bjp.140.6.566CrossRef

20.

Troyer AK, Moscovitch M, Winocur G, Leach L, Freedman M (1998) Clustering and switching on verbal fluency tests in Alzheimer’s and Parkinson’s disease. J Int Neuropsychol Soc 4(2):137–143. https://doi.org/10.1017/s1355617798001374CrossRefPubMed

21.

Rosen WG (1980) Verbal fluency in aging and dementia. J Clin Neurosci 2(2):135–146

22.

Monsch AU, Bondi MW, Butters N, Salmon DP, Katzman R, Thal LJ (1992) Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol 49(12):1253–1258CrossRef

23.

Piatt AL, Fields JA, Paolo AM, Tröster AI (1999) Action (verb naming) fluency as an executive function measure: convergent and divergent evidence of validity. Neuropsychologia. 37(13):1499–1503CrossRef

24.

Piatt AL, Fields JA, Paolo AM, Tröster AI (2004) Action verbal fluency normative data for the elderly. Brain Lang 89(3):580–583CrossRef

25.

Sgaramella TM, Borgo F, Mondini S, Pasini M, Toso V, Semenza C (2001) Executive deficits appearing in the initial stage of Alzheimer’s disease. Brain Cogn 46(1–2):264–268CrossRef

26.

Perry RJ, Hodges JR (1999) Attention and executive deficits in Alzheimer’s disease. A critical review. Brain J Neurol 122(3):383–404CrossRef

27.

Griffith HR, Netson KL, Harrell LE, Zamrini EY, Brockington JC, Marson DC (2006) Amnestic mild cognitive impairment: diagnostic outcomes and clinical prediction over a two-year time period. J Int Neuropsychol Soc 12(02)

28.

Kramer JH, Nelson A, Johnson JK, Yaffe K, Glenn S, Rosen HJ, Miller BL (2006) Multiple cognitive deficits in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord. 22(4):306–311CrossRef

29.

Kessels RPC, Molleman PW, Oosterman JM (2011) Assessment of working-memory deficits in patients with mild cognitive impairment and Alzheimer’s dementia using Wechsler’s Working Memory Index. Aging Clin Exp Res 23(5–6):487–490CrossRef

30.

Petersen RC, Smith GE, Ivnik RJ, Kokmen E, Tangalos EG (1994) Memory function in very early Alzheimer’s disease. Neurology. 44(5):867–872CrossRef

31.

Estévez-González A, García-Sánchez C, Boltes A, Otermín P, Pascual-Sedano B, Gironell A, Kulisevsky J (2004) Semantic knowledge of famous people in mild cognitive impairment and progression to Alzheimer’s disease. Dement Geriatr Cogn Disord 17(3):188–195CrossRef

32.

Arango-Lasprilla JC, Cuetos F, Valencia C, Uribe C, Lopera F (2007) Cognitive changes in the preclinical phase of familial Alzheimer’s disease. J Clin Exp Neuropsychol 29:892–900CrossRef

33.

Thompson SA, Graham KS, Patterson K, Sahakian BJ, Hodges JR (2002) Is knowledge of famous people disproportionately impaired in patients with early and questionable Alzheimer’s disease? Neuropsychology. 16(3):344–358CrossRef

34.

García S, Cuetos F, Novelli A, Martínez C (2020) Famous faces naming test predicts conversion from mild cognitive impairment to Alzheimer’s disease. Acta Neurol Belg. https://doi.org/10.1007/s13760-020-01483-3

Titel: A new and short protocol to achieve the early diagnosis of mild cognitive impairment
verfasst von: Sara García
Fernando Cuetos
Antonello Novelli
Carmen Martínez
Publikationsdatum: 13.01.2021
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 9/2021
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-021-05044-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2021

Preclinical studies of mesenchymal stem cells transplantation in amyotrophic lateral sclerosis: a systemic review and metaanalysis

MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine

A novel Q93H missense mutation in DCTN1 caused distal hereditary motor neuropathy type 7B and Perry syndrome from a Chinese family

A rare patient with idiopathic intracranial hypertension without papilledema presenting with tinnitus

Epilepsy and quality of life: what does really matter?